» Articles » PMID: 36707068

Are Menopause, Aging and Prostate Cancer Diseases?

Overview
Specialty Geriatrics
Date 2023 Jan 27
PMID 36707068
Authors
Affiliations
Soon will be listed here.
Abstract

There is no doubt that prostate cancer is a disease. Then, according to hyperfunction theory, menopause is also a disease. Like all age-related diseases, it is a natural process, but is also purely harmful, aimless and unintended by nature. But exactly because these diseases (menopause, prostate enlargement, obesity, atherosclerosis, hypertension, diabetes, presbyopia and thousands of others) are partially quasi-programmed, they can be delayed by slowing aging. Is aging a disease? Aging is a quasi-programmed disease that is partially treatable by rapamycin. On the other hand, aging is an abstraction, a sum of all quasi-programmed diseases and processes. In analogy, the zoo consists of animals and does not exist without animals, but the zoo is not an animal.

Citing Articles

Mikhail 'Misha' Blagosklonny's enduring legacy in geroscience: the hyperfunction theory and the therapeutic potential of rapamycin.

Barzilai D Aging (Albany NY). 2025; 17(1):1-15.

PMID: 39808121 PMC: 11810056. DOI: 10.18632/aging.206189.


Altered brain morphology and functional connectivity in postmenopausal women: automatic segmentation of whole-brain and thalamic subnuclei and resting-state fMRI.

Kim G, Park K, Kim Y, Jeong G Aging (Albany NY). 2024; 16(6):4965-4979.

PMID: 38526330 PMC: 11006480. DOI: 10.18632/aging.205662.


My battle with cancer. Part 1.

Blagosklonny M Oncoscience. 2024; 11:1-14.

PMID: 38188499 PMC: 10765422. DOI: 10.18632/oncoscience.593.


Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?.

Blagosklonny M Aging (Albany NY). 2023; 15(14):6632-6640.

PMID: 37477535 PMC: 10415559. DOI: 10.18632/aging.204920.

References
1.
Rehnitz J, Messmer B, Bender U, Nguyen X, Germeyer A, Hinderhofer K . Activation of AKT/mammalian target of rapamycin signaling in the peripheral blood of women with premature ovarian insufficiency and its correlation with FMR1 expression. Reprod Biol Endocrinol. 2022; 20(1):44. PMC: 8898473. DOI: 10.1186/s12958-022-00919-0. View

2.
Laberge R, Sun Y, Orjalo A, Patil C, Freund A, Zhou L . MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol. 2015; 17(8):1049-61. PMC: 4691706. DOI: 10.1038/ncb3195. View

3.
Blagosklonny M . An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Discov Today. 2007; 12(5-6):218-24. DOI: 10.1016/j.drudis.2007.01.004. View

4.
Wang H, Zhang Z, Gems D . Monsters in the uterus: teratoma-like tumors in senescent result from a parthenogenetic quasi-program. Aging (Albany NY). 2018; 10(6):1188-1189. PMC: 6046241. DOI: 10.18632/aging.101486. View

5.
Adhikari D, Zheng W, Shen Y, Gorre N, Hamalainen T, Cooney A . Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles. Hum Mol Genet. 2009; 19(3):397-410. PMC: 2798719. DOI: 10.1093/hmg/ddp483. View